Palleon is a biotechnology company focused on developing novel cancer therapies that target the immune system. Their approach involves modulating the immune checkpoint pathways to enhance the body’s immune response against cancer cells. Palleon’s goal is to develop precision therapies that have the potential to treat a broad range of cancers and improve patient outcomes.